| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $5.85B | -6.0% |
| Cost of Revenue | $4.38B | -0.7% |
| Gross Profit | $1.47B | -19.1% |
| R&D Expense | $18.9M | -42.7% |
| SG&A Expense | $904.7M | -7.1% |
| Operating Income | $415.6M | -36.6% |
| Interest Expense | $317.8M | -15.4% |
| Pre-tax Income | $895.3M | +165.5% |
| Income Tax | $85.7M |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $586.5M | -28.2% |
| Accounts Receivable | $544.2M | -1.8% |
| Inventory | $549.1M | -7.6% |
| Current Assets | $2.22B | +6.6% |
| Total Assets | $11.31B | -8.9% |
| Current Liabilities | $823.8M | -21.5% |
| Long-term Debt | $5.96B | -14.0% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $382.6M | -35.0% |
| Investing Cash Flow | -$221.0M | +72.2% |
| Financing Cash Flow | -$386.7M | -130.9% |
| -1.0% |
| Net Income | $756.6M | +353.9% |
| EPS (Basic) | $12.42 | +413.2% |
| EPS (Diluted) | $12.09 | +408.0% |
| Total Liabilities |
| $7.74B |
| -17.3% |
| Stockholders' Equity | $3.25B | +18.7% |